The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia

Leukemia. 2020 Sep;34(9):2479-2483. doi: 10.1038/s41375-020-0755-7. Epub 2020 Feb 18.

Colin D Godwin^#^{1

2}, George S Laszlo^#¹, Brent L Wood³, Colin E Correnti¹, Olivia M Bates¹, Eliotte E Garling¹, Zhengwei J Mao³, Mary E Beddoe¹, Margaret C Lunn¹, Olivier Humbert¹, Hans-Peter Kiem^{1

4

5}, Roland B Walter^{6

7

8

9}

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
³ Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
⁴ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
⁵ Department of Pathology, University of Washington, Seattle, WA, USA.
⁶ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rwalter@fredhutch.org.
⁷ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.
⁸ Department of Pathology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.
⁹ Department of Epidemiology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.

^# Contributed equally.

No abstract available

Publication types